PHARMO Institute study presented at ISPOR Europe 2022 (6-9 Nov)
At ISPOR Europe 2022 in Vienna, the INTREPID Trial study, to which the PHARMO Institute
25 October 2022
At ISPOR Europe 2022 in Vienna, the INTREPID Trial study, to which the PHARMO Institute
This study describes treatment patterns, low-density lipoprotein cholesterol (LDL-C) levels and healthcare resource utilization (HCRU)
“More and more people are living with cancer. It is expected that the number of
PHARMO is op zoek naar een junior onderzoeker ter ondersteuning van de afdeling Onderzoek. In
PHARMO Institute is looking for a Sr. Researcher. See our vacancy in Dutch. PHARMO Institute
PHARMO Institute at ICPE Copenhagen The PHARMO Institute team had a great time at
Scientific annual report 2021 Read all about our work in 2021 in our Scientific Annual